- Q3 revenues dropped substantially alongside an Adjusted EBITDA loss of $4.6M.
- Net loss expanded to $32.7M (Adjusted Net Loss of $18.7M) with negative 30% net margin.
- Gross margin compressed significantly across core segments year-over-year.
Why is $EBS moving today? · SEC 8-K archive
$EBS SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $EBS: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $EBS filing catalyst
Why did $EBS trigger an AI stock catalyst alert?
$EBS triggered a Stock Catalyst AI alert on 2026-11-02 00:00:00 UTC for a SEC 8-K filing (AI Score: -6.5/10). Headline: Emergent BioSolutions Reports Q3 Net Loss of $32.7M on Sharp Revenue Decline. Key points: - Q3 revenues dropped substantially alongside an Adjusted EBITDA loss of $4.6M. - Net loss expanded to $32.7M (Adjusted Net Loss of $18.7M) with negative 30% net margin. - Gross margin compressed significantly across core segments year-over-year.
How did $EBS stock react after the SEC filing?
After the SEC 8-K for $EBS, observed market reaction: T0 price $6.43. Past moves do not guarantee future results.
Where can I get real-time $EBS SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $EBS via Telegram and the VIP Web Terminal from €10/month.